全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Idiopathic Thrombocytopenic Purpura after Mastectomy and Axillary Lymph Node Dissection

DOI: 10.1155/2014/316064

Full-Text   Cite this paper   Add to My Lib

Abstract:

First described in 1916, idiopathic thrombocytopenic purpura (ITP) is an autoimmune disease resulting in the destruction of platelets. Here, we present a case of an 85-year-old patient diagnosed with invasive ductal carcinoma of the breast whose surgical treatment was complicated postoperatively by acute-onset thrombocytopenia with a resultant hematoma at the operative site. Diagnostic Workup revealed no clear etiology for the thrombocytopenia; therefore, a presumptive diagnosis of idiopathic thrombocytopenic purpura was made. Previous literature has associated the development of idiopathic thrombocytopenic purpura with breast cancer. However, to the authors’ knowledge, there are no reported cases of ITP presenting immediately following surgical intervention for breast cancer in the absence of other etiologic factors. 1. Introduction Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disease, first described in 1916 [1], in which autoantibody production results in destruction of platelets and thrombocytopenia [2]. Prior reports of ITP in patients diagnosed with breast cancer exist where ITP preceded the diagnosis of breast cancer [3] or occurred during adjuvant therapy [4, 5] or metastatic breast cancer was discovered upon therapeutic splenectomy for ITP [6]. Here, we report a case of idiopathic thrombocytopenic purpura which presented after mastectomy for invasive ductal carcinoma. 2. Case Report An 85-year-old Caucasian, postmenopausal female presented to the outpatient clinic with a palpable mass in her left breast. Initial diagnostic mammography identified spiculation and architectural distortion inferior to the 2.1 cm mass at the 12 o’clock position of the left breast. Targeted left breast ultrasound demonstrated two distinct hypoechoic lesions in the 12:00 axis of her left breast, which was classified as BIRADS-5. Ultrasound-guided biopsy revealed invasive ductal carcinoma (ER positive, PR positive, and Her2-Neu negative) in three different areas within her left breast. Left modified radical mastectomy with sentinel lymph node biopsy and axillary lymph node dissection was performed. Three of six sentinel lymph nodes were found to be positive on frozen section (one with macrometastasis and two with micrometastasis), and a full axillary lymph node dissection was performed. The patient was convalescing satisfactorily until the afternoon of postoperative day one, when the output of her surgical drains became sanguineous and voluminous. A pressure dressing was applied to the chest wall. On postoperative day two, her hemoglobin had dropped to

References

[1]  R. Stasi and A. C. Newland, “ITP: a historical perspective,” British Journal of Haematology, vol. 153, no. 4, pp. 437–450, 2011.
[2]  K. Fink and H. Al Mondhiry, “Idiopathic thrombocytopenic purpura in lymphoma,” Cancer, vol. 37, no. 4, pp. 1999–2004, 1976.
[3]  R. Gencosmanoglu, P. Unalan, G. Kir, and R. Inceoglu, “Breast cancer and immune thrombocytopenic purpura: is there any association between these 2 distinct diseases?” Breast Care, vol. 2, no. 5, pp. 317–320, 2007.
[4]  L. F. Porrata, S. Alberts, C. Hook, and C. A. Hanson, “Idiopathic thrombocytopenic purpura associated with breast cancer: a case report and review of the current literature,” American Journal of Clinical Oncology, vol. 22, no. 4, pp. 411–413, 1999.
[5]  C. Ustun, P. Dainer, and L. Hendricks, “Association of breast cancer and immune thrombocytopenic purpura,” Southern Medical Journal, vol. 95, no. 11, pp. 1335–1337, 2002.
[6]  O. W. Cummings and M. T. Mazur, “Breast carcinoma diffusely metastatic to the spleen: a report of two cases presenting as idiopathic thrombocytopenic purpura,” American Journal of Clinical Pathology, vol. 97, no. 4, pp. 484–489, 1992.
[7]  P. E. Abrahamson, S. A. Hall, M. Feudjo-Tepie, F. S. Mitrani-Gold, and J. Logie, “The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review,” European Journal of Haematology, vol. 83, no. 2, pp. 83–89, 2009.
[8]  S. Lakshmanan and A. Cuker, “Contemporary management of primary immune thrombocytopenia in adults,” Journal of Thrombosis and Haemostasis, vol. 10, pp. 1988–1998, 2012.
[9]  R. P. de Latour, G. des Guetz, V. Laurence et al., “Breast cancer associated with idiopathic thrombocytopenic purpura: a single center series of 10 cases,” American Journal of Clinical Oncology, vol. 27, no. 4, pp. 333–336, 2004.
[10]  M. A. Samimi, N. Mirkheshti, M. Heidarpour, and M. Abdollahi, “Idiopathic thrombocytopenic purpura in women with breast cancer,” Journal of Research in Medical Sciences, vol. 15, no. 6, pp. 359–363, 2010.
[11]  T. Sailer, K. Lechner, S. Panzer, P. A. Kyrle, and I. Pabinger, “The course of severe autoimmune thrombocytopenia in patients not undergoing splenectomy,” Haematologica, vol. 91, no. 8, pp. 1041–1045, 2006.
[12]  K. Kojouri, S. K. Vesely, D. R. Terrell, and J. N. George, “Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications,” Blood, vol. 104, no. 9, pp. 2623–2634, 2004.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413